Truth matters. Community matters. Your support makes both possible. LAist is one of the few places where news remains independent and free from political and corporate influence. Stand up for truth and for LAist. Make your year-end tax-deductible gift now.
This archival content was originally written for and published on KPCC.org. Keep in mind that links and images may no longer work — and references may be outdated.
Researchers step closer to treating 'inflammatory' molecules behind diabetes, arthritis, strokes, heart disease
File: A researcher at CS/ECE wears a lab coat.
(
TracerBullet999/Flickr
)
Listen
0:41
Researchers step closer to treating 'inflammatory' molecules behind diabetes, arthritis, strokes, heart disease
Researchers step closer to treating 'inflammatory' molecules behind diabetes, arthritis, strokes, heart disease
Researchers at Cedars-Sinai have moved a step closer to better treatment of arthritis, diabetes and a number of other diseases caused in part by inflammation, and it all starts with a tiny molecule.
The new finding may help create medications that will stop our bodies from over-producing a molecule called “interluekin-1 beta.” That molecule is a contributor to Type 2 diabetes, rheumatoid arthritis, some strokes and heart disease.
Until now, treatment focused on blocking the molecule only after our bodies created it.
But Cedars-Sinai researchers say they now have a better understanding of how the body produces the molecule in the first place — an important step toward new medications that will stop the molecule’s production before it starts, leading to better treatment of inflammatory diseases that affect an estimated 100 million Americans.
You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.
Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive before year-end will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.
If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Your tax-deductible donation keeps LAist independent and accessible to everyone.
Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive before year-end will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.
If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief
